Taiwanese drug maker Adimmune Corp. on Thursday said it has started the first phase of human trials for its experimental COVID-19 vaccine this week, with Phase 2 likely to follow in November if everything goes well.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar higher in Taipei trading
09/18/2025 10:54 AM - Business
Taiwan pledges US$10 billion in U.S. farm product purchases over four years
09/18/2025 10:51 AM - Society
Taiwan headline news
09/18/2025 10:21 AM - Business
Taiwan shares open higher
09/18/2025 09:24 AM - Business
Taipower activates 5 standby units to cope with low power reserve
09/17/2025 11:13 PM